Your browser doesn't support javascript.
loading
Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development.
Ballmann, Mónika Z; Raus, Svjetlana; Engelhart, Ruben; Kaján, Gyozo L; Beqqali, Abdelaziz; Hadoke, Patrick W F; van der Zalm, Chantal; Papp, Tibor; John, Lijo; Khan, Selina; Boedhoe, Satish; Danskog, Katarina; Frängsmyr, Lars; Custers, Jerome; Bakker, Wilfried A M; van der Schaar, Hilde M; Arnberg, Niklas; Lemckert, Angelique A C; Havenga, Menzo; Baker, Andrew H.
Afiliação
  • Ballmann MZ; Batavia Biosciences B.V., Leiden, The Netherlands.
  • Raus S; Centre for Cardiovascular Sciences, University of Edinburghgrid.4305.2, Edinburgh, United Kingdom.
  • Engelhart R; Batavia Biosciences B.V., Leiden, The Netherlands.
  • Kaján GL; Centre for Cardiovascular Sciences, University of Edinburghgrid.4305.2, Edinburgh, United Kingdom.
  • Beqqali A; Department of Clinical Microbiology, Division of Virology, Umeå University, Umeå, Sweden.
  • Hadoke PWF; Centre for Cardiovascular Sciences, University of Edinburghgrid.4305.2, Edinburgh, United Kingdom.
  • van der Zalm C; Centre for Cardiovascular Sciences, University of Edinburghgrid.4305.2, Edinburgh, United Kingdom.
  • Papp T; Batavia Biosciences B.V., Leiden, The Netherlands.
  • John L; Janssen Vaccines and Prevention B.V., Leiden, The Netherlands.
  • Khan S; Department of Clinical Microbiology, Division of Virology, Umeå University, Umeå, Sweden.
  • Boedhoe S; Janssen Vaccines and Prevention B.V., Leiden, The Netherlands.
  • Danskog K; Janssen Vaccines and Prevention B.V., Leiden, The Netherlands.
  • Frängsmyr L; Department of Clinical Microbiology, Division of Virology, Umeå University, Umeå, Sweden.
  • Custers J; Department of Clinical Microbiology, Division of Virology, Umeå University, Umeå, Sweden.
  • Bakker WAM; Janssen Vaccines and Prevention B.V., Leiden, The Netherlands.
  • van der Schaar HM; Batavia Biosciences B.V., Leiden, The Netherlands.
  • Arnberg N; Batavia Biosciences B.V., Leiden, The Netherlands.
  • Lemckert AAC; Department of Clinical Microbiology, Division of Virology, Umeå University, Umeå, Sweden.
  • Havenga M; Batavia Biosciences B.V., Leiden, The Netherlands.
  • Baker AH; Batavia Biosciences B.V., Leiden, The Netherlands.
J Virol ; 95(22): e0038721, 2021 10 27.
Article em En | MEDLINE | ID: mdl-34469243
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Adenovírus Humanos / Vetores Genéticos / Desenvolvimento de Vacinas Limite: Animals / Humans / Male Idioma: En Revista: J Virol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Adenovírus Humanos / Vetores Genéticos / Desenvolvimento de Vacinas Limite: Animals / Humans / Male Idioma: En Revista: J Virol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos